reputable retatrutide supplier Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Is Retatrutide The Best Weight

If youre one of the many people who are curious about Ozempic, you may know that its not one of the cheapest medications on the market, averaging over $1,300 per month without insurance

Lillys tirzepatide delivered up to 22.5% weight loss in adults with obesity or overweight in SURMOUNT-1, Eli Lilly (2022) There are upcoming changes to your plans drug coverage and we want to be sure youre ready, Aetna (2025) Pharmacy clinical policy bulletins Aetna non-Medicare prescription drug plan, Aetna (2024) Aetna Better Health coverage policy guideline, Aetna (2025) Medicine search tool, Aetna (2025) FDA approves new medication for chronic weight management, U.S

Tomorrow: Automated insulin delivery beat standard insulin in Type 2 Diabetes

These treatments have gained FDA approval for use in adults struggling with obesity or overweight conditions linked to health risks

Retatrutide simultaneously targets GLP-1, GIP, and glucagon receptors a mechanism that sets it apart from approved medicines such as semaglutide and tirzepatide

Why it matters: A projected launch window is not the same as FDA approval